-
公开(公告)号:US20180338467A1
公开(公告)日:2018-11-29
申请号:US15984857
申请日:2018-05-21
Applicant: NESTEC SA
Inventor: Ebenezer Satyaraj , Peichuan Sun , Scott Sherrill , Qinghong Li , Steven Hannah
Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.
-
公开(公告)号:US10405563B2
公开(公告)日:2019-09-10
申请号:US15686893
申请日:2017-08-25
Applicant: Nestec SA
Inventor: Qinghong Li
IPC: A01N63/00 , A61K49/00 , A01N65/00 , A23K50/40 , A23K20/147 , A23K20/158 , A23K20/10 , A61K35/741 , A23K10/16 , A23K10/18 , A61K35/00
Abstract: The present invention relates to methods and compositions for modulating gastrointestinal microflora of a canine. In one embodiment, a method of modulating gastrointestinal microflora in a canine can comprise administering to the canine a pet food composition comprising from about 25% to about 60% protein, from about 5% to about 30% carbohydrates, fat, and fiber; where after administration, the Bacteroidetes to Firmicutes (B/F) ratio of the canine is less than 0.8.
-
公开(公告)号:US20180064140A1
公开(公告)日:2018-03-08
申请号:US15686893
申请日:2017-08-25
Applicant: Nestec SA
Inventor: Qinghong Li
IPC: A23K50/40 , A61K35/741 , A23K20/147 , A23K20/158 , A23K20/10
CPC classification number: A23K50/40 , A23K10/16 , A23K10/18 , A23K20/10 , A23K20/147 , A23K20/158 , A61K35/741 , A61K2035/115
Abstract: The present invention relates to methods and compositions for modulating gastrointestinal microflora of a canine. In one embodiment, a method of modulating gastrointestinal microflora in a canine can comprise administering to the canine a pet food composition comprising from about 25% to about 60% protein, from about 5% to about 30% carbohydrates, fat, and fiber; where after administration, the Bacteroidetes to Firmicutes (B/F) ratio of the canine is less than 0.8.
-
公开(公告)号:US11102952B2
公开(公告)日:2021-08-31
申请号:US15984857
申请日:2018-05-21
Applicant: NESTEC SA
Inventor: Ebenezer Satyaraj , Peichuan Sun , Scott Sherrill , Qinghong Li , Steven Hannah
Abstract: The present disclosure provides methods for enabling an individual having a cat allergy to have a cat as a pet. Such a method can include quantitatively determining a threshold in the individual for an environmental level of an allergen produced by the cat and selecting a cat or a breed of cat that creates an environmental level of the allergen that is less than the threshold. Additionally, such a method can include lowering the allergens disseminated by the cat by treating the environment inhabited by the cat during a time period where the cat expresses elevated allergens.
-
公开(公告)号:US20190240180A1
公开(公告)日:2019-08-08
申请号:US16265180
申请日:2019-02-01
Applicant: NESTEC SA
Inventor: Qinghong Li , George Arthur Bailey Wells
IPC: A61K31/20 , A61K31/202 , A61K31/198 , A61K31/197 , A61K31/355 , A61K33/06 , A61K31/185 , A61P9/12 , A23K20/158 , A23K20/174 , A23K20/142 , A23K20/24 , A23K50/40
CPC classification number: A61K31/20 , A23K20/142 , A23K20/158 , A23K20/174 , A23K20/24 , A23K50/40 , A61K31/185 , A61K31/197 , A61K31/198 , A61K31/202 , A61K31/205 , A61K31/355 , A61K33/06 , A61P9/12 , A61P13/12 , A61K2300/00
Abstract: A method for reducing blood pressure or treating renal or kidney disease in a companion animal, the method comprising orally administering a composition comprising a therapeutically effective amount of medium chain triglycerides to the companion animal.
-
公开(公告)号:US20160237495A1
公开(公告)日:2016-08-18
申请号:US15015318
申请日:2016-02-04
Applicant: NESTEC SA
Inventor: Qinghong Li
IPC: C12Q1/68
CPC classification number: C12Q1/6883 , C12Q2600/158 , C12Q2600/178
Abstract: The invention provides methods for diagnosing chronic valvular disease in an animal. The methods comprise obtaining a sample from the animal; analyzing the sample for an amount of a microRNA (miRNA) associated with chronic valvular disease; comparing the amount of the miRNA identified in the sample to a corresponding amount of the miRNA present in a sample from one or more comparable control animals that do not suffer from chronic valvular disease; and diagnosing the animal with chronic valvular disease if the amount of the miRNA found in the animal's sample is differentially expressed in the control animal's sample.
Abstract translation: 本发明提供用于诊断动物中慢性瓣膜疾病的方法。 所述方法包括从动物获得样品; 分析样品中与慢性瓣膜疾病相关的微小RNA(miRNA)的量; 将样品中鉴定的miRNA的量与来自不患有慢性瓣膜病的一种或多种可比对照动物的样品中存在的相应量的miRNA进行比较; 并且如果动物样品中发现的miRNA的量在对照动物样品中差异表达,则诊断具有慢性瓣膜疾病的动物。
-
公开(公告)号:US20150153353A1
公开(公告)日:2015-06-04
申请号:US14405325
申请日:2013-06-04
Applicant: NESTEC SA
Inventor: Qinghong Li , Dorothy P. Laflamme , Steven S. Hannah
CPC classification number: G01N33/6812 , G01N33/50 , G01N33/92 , G01N2570/00 , G01N2800/326 , Y10T436/142222 , Y10T436/143333 , Y10T436/163333 , Y10T436/201666
Abstract: The invention provides methods for diagnosing chronic valvular disease in an animal. The methods comprise obtaining a sample from the animal; analyzing the sample for the presence of one or more metabolites associated with chronic valvular disease; comparing the amount of each such metabolite identified in the sample to a corresponding amount of the same metabolite present in a sample from one or more comparable control animals that do not suffer from chronic valvular disease; and using said comparison to diagnose chronic valvular disease in the animal if the metabolites found in the animal's sample is greater than or less than the amount present in the control animal's sample.
Abstract translation: 本发明提供用于诊断动物中慢性瓣膜疾病的方法。 所述方法包括从动物获得样品; 分析样品中存在与慢性瓣膜疾病相关的一种或多种代谢物; 将样品中鉴定的每种这样的代谢物的量与来自不患有慢性瓣膜疾病的一种或多种可比对照动物的样品中存在的相同代谢物的相应量相比较; 并且如果动物样品中发现的代谢物大于或小于对照动物样品中存在的量,则使用所述比较来诊断动物中的慢性瓣膜病。
-
-
-
-
-
-